However, we did not observe a correlation between FGF19 upregulation and response to BLU.9931 in the human HCC cell lines (Figure 5D), which may be explained by the poor correlation between the FGFR4 and FGF19 protein expressions (Figure 5E). The gene discussed is FGFR4; the disease is hepatocellular carcinoma.